<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02854475</url>
  </required_header>
  <id_info>
    <org_study_id>Raman 2016.1</org_study_id>
    <nct_id>NCT02854475</nct_id>
  </id_info>
  <brief_title>Confocal Raman Spectroscopy: in Vivo Measurement of Physiological Skin Parameters</brief_title>
  <official_title>Confocal Raman Spectroscopy: in Vivo Measurement of Physiological Skin Parameters - A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to

      I. determine several skin parameters, for example natural moisturizing factor (NMF) and
      cholesterol, with Raman spectroscopy in vivo and

      II. compare the results with the corresponding cholesterol levels measured in venous blood.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In vivo Raman experiments will be carried out weekly on voluntary participants using a
      RiverDiagnostics gen2-SCA Skin Composition Analyzer (RiverDiagnostics, Rotterdam,
      Netherlands). All experiments will be carried out on the volar forearm. Semi-quantitative
      concentration profiles for several skin parameters will be determined, for example natural
      moisturizing factor (NMF) and cholesterol.

      Additionally the total cholesterol level will be detected by venous blood sample analysis.
      The blood samples will be taken weekly within two weeks, similar to the Raman measurements.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation of the fasting total cholesterol levels measured in skin with confocal Raman spectroscopy and in venous blood collected by venipuncture</measure>
    <time_frame>2 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Concentration curves of various skin substances, such as NMF, urea and water as evidence for the eligibility of confocal Raman spectroscopy for the in vivo measurement of skin</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Dermatologic Disorders</condition>
  <condition>Disorder of Cholesterol Metabolism</condition>
  <arm_group>
    <arm_group_label>Proband group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Raman spectroscopy and venous blood collection</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Venous blood collection</intervention_name>
    <description>weekly within two weeks</description>
    <arm_group_label>Proband group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Raman spectroscopy</intervention_name>
    <description>weekly within two weeks, on the volar forearm, using a RiverDiagnostics gen2-SCA Skin Composition Analyzer</description>
    <arm_group_label>Proband group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Provision of subject informed consent

          -  Female or male aged between 18 and 65 years

        Exclusion Criteria:

          -  Pregnancy

          -  Chronic skin conditions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 27, 2016</study_first_submitted>
  <study_first_submitted_qc>July 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 3, 2016</study_first_posted>
  <last_update_submitted>July 29, 2016</last_update_submitted>
  <last_update_submitted_qc>July 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Vienna</investigator_affiliation>
    <investigator_full_name>Lisa Binder</investigator_full_name>
    <investigator_title>Mag. pharm.</investigator_title>
  </responsible_party>
  <keyword>skin parameters</keyword>
  <keyword>cholesterol</keyword>
  <keyword>Raman spectroscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Skin Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

